Pericyte loss initiates microvascular dysfunction in the development of diastolic dysfunction

Steven J Simmonds, Mandy O J Grootaert, Ilona Cuijpers, Paolo Carai, Nadeche Geuens, Melissa Herwig, Pieter Baatsen, Nazha Hamdani, Aernout Luttun, Stephane Heymans, Elizabeth A V Jones*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

AIMS: Microvascular dysfunction has been proposed to drive heart failure with preserved ejection fraction (HFpEF), but the initiating molecular and cellular events are largely unknown. Our objective was to determine when microvascular alterations in HFpEF begin, how they contribute to disease progression, and how pericyte dysfunction plays a role herein. METHODS AND RESULTS: Microvascular dysfunction, characterized by inflammatory activation, loss of junctional barrier function, and altered pericyte-endothelial crosstalk, was assessed with respect to the development of cardiac dysfunction, in the Zucker fatty and spontaneously hypertensive (ZSF1) obese rat model of HFpEF at three time points: 6, 14, and 21 weeks of age. Pericyte loss was the earliest and strongest microvascular change, occurring before prominent echocardiographic signs of diastolic dysfunction were present. Pericytes were shown to be less proliferative and had a disrupted morphology at 14 weeks in the obese ZSF1 animals, who also exhibited an increased capillary luminal diameter and disrupted endothelial junctions. Microvascular dysfunction was also studied in a mouse model of chronic reduction in capillary pericyte coverage ( ), which spontaneously developed many aspects of diastolic dysfunction. Pericytes exposed to oxidative stress showed downregulation of cell cycle-associated pathways and induced a pro-inflammatory state in endothelial cells upon co-culture. CONCLUSION: We propose pericytes are important for maintaining endothelial cell function, where loss of pericytes enhances the reactivity of endothelial cells to inflammatory signals and promotes microvascular dysfunction, thereby accelerating the development of HFpEF.
Original languageEnglish
Article numberoead129
Number of pages13
JournalEuropean heart journal open
Volume4
Issue number1
DOIs
Publication statusPublished - Jan 2024

Keywords

  • HFpEF
  • Metabolic comorbidities
  • Microvascular dysfunction
  • Pericytes

Cite this